• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 3. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 4. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 5. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696

Comprehensive Overview of (2-Bromooxazol-5-yl)methanol (CAS No. 1092351-98-8): Properties, Applications, and Industry Insights

(2-Bromooxazol-5-yl)methanol (CAS No. 1092351-98-8) is a specialized organic compound that has garnered significant attention in pharmaceutical and agrochemical research due to its unique structural features. This brominated oxazole derivative serves as a versatile building block in synthetic chemistry, particularly in the development of heterocyclic compounds. The presence of both bromo and hydroxymethyl functional groups on the oxazole ring enables diverse chemical modifications, making it valuable for drug discovery and material science applications.

Recent trends in AI-driven drug design and high-throughput screening have increased demand for structurally complex intermediates like (2-Bromooxazol-5-yl)methanol. Researchers frequently search for "oxazole derivatives in medicinal chemistry" or "brominated heterocycles synthesis," reflecting its growing importance. The compound's molecular weight of 178.00 g/mol and lipophilicity (predicted LogP ≈ 1.2) make it particularly useful for developing bioactive molecules with improved membrane permeability.

From a synthetic chemistry perspective, (2-Bromooxazol-5-yl)methanol offers multiple reactive sites for cross-coupling reactions, nucleophilic substitutions, and oxazole ring functionalization. Its crystalline form (typically white to off-white powder) and moderate solubility in polar organic solvents facilitate various organic transformations. Current literature highlights its application in creating kinase inhibitors, with particular interest in "oxazole-based anticancer agents" – a trending topic in pharmaceutical forums.

The spectroscopic characterization of 1092351-98-8 reveals distinctive features: 1H NMR shows signals at δ 4.70 (s, 2H) for the hydroxymethyl group and δ 7.90 (s, 1H) for the oxazole proton, while 13C NMR displays characteristic peaks between 150-160 ppm for the heterocyclic carbons. These spectral fingerprints are crucial for quality control in contract manufacturing organizations (CMOs), where searches for "NMR data of bromooxazole derivatives" have increased by 40% year-over-year.

In green chemistry applications, researchers are exploring catalytic methods to synthesize (2-Bromooxazol-5-yl)methanol with reduced environmental impact. This aligns with the growing "sustainable heterocycle synthesis" trend, where scientists seek alternatives to traditional halogenation protocols. The compound's thermal stability (decomposition >200°C) also makes it suitable for high-temperature reactions in flow chemistry systems – a hot topic in process chemistry optimization.

From a commercial perspective, 1092351-98-8 is primarily supplied by specialty chemical manufacturers serving the pharmaceutical intermediates market. Pricing trends show seasonal fluctuations corresponding with academic research cycles, with peak demand during grant proposal seasons. Analytical certificates typically specify ≥95% purity by HPLC analysis, with some suppliers offering custom synthesis options for specific enantiomeric purity requirements.

Emerging applications in electronic materials have expanded interest in this compound, particularly for creating oxazole-containing semiconductors. The conjugated system of the oxazole ring, combined with the bromine atom's heavy atom effect, shows promise for organic light-emitting diodes (OLEDs) – answering frequent queries about "heterocycles in optoelectronics." This dual applicability in life sciences and material science positions (2-Bromooxazol-5-yl)methanol as a compound with cross-disciplinary value.

Storage and handling recommendations for CAS 1092351-98-8 include protection from moisture (recommended desiccated storage at 2-8°C) due to potential hydrolysis of the hydroxymethyl group. Stability studies indicate excellent shelf life (>24 months) when properly stored, addressing common concerns about "heterocyclic compound stability" in research communities. Transportation typically follows standard protocols for laboratory chemicals, with proper documentation of chemical compatibility.

The intellectual property landscape shows increasing patent activity surrounding oxazole derivatives, with 1092351-98-8 appearing in several drug candidate claims. This correlates with rising searches for "privileged structures in medicinal chemistry" – a concept where certain scaffolds like oxazoles frequently appear in bioactive compounds. Current clinical pipeline analysis suggests at least three Phase II candidates incorporating similar brominated heterocycles as key structural elements.

For researchers considering (2-Bromooxazol-5-yl)methanol in their work, recent synthetic methodology papers describe improved routes using microwave-assisted synthesis or continuous flow techniques. These advancements address the frequent query "how to synthesize bromooxazole derivatives" while meeting modern process intensification standards. The compound's scalability has been demonstrated at kilogram scale, supporting its transition from discovery chemistry to development pipelines.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)